| Project | Product | Disease | Discovery | Development | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Target Discovery |
Hit | Lead | L/O | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | Launched | |||
| SHADD |
HCB-5022 HCB-5018 HCB-5009 |
폐염증, 건선, 루프스, 아토피, 골다공증, 건선 … | |||||||||
| New Scaffold | |||||||||||
| Biological Testing ~ PI Drugs First-in-class |
|||||||||||
| PII ~ Launched Drugs Best-in-class |
|||||||||||
| EGFR 4세대 | cancer | ||||||||||
| Linker / Hybrid | Alzheimer's / Cancer | ||||||||||